AeroEclipse II BAN

The AeroEclipse® II  Breath Actuated Nebulizer (BAN) creates aerosol in response to the patient’s inspiratory flow.  This patient on-demand therapy means less medication waste, higher drug delivery efficiency and safer clinician working environments. Combining the benefits of breath actuation and a superior aerosol particle size, the BAN™ delivers the industry’s most effective respirable dose. Supported by clinical evidence, the BAN™, provides approved dosing protocols throughout the hospital and for all patient populations. THE FACTS The AeroEclipse® II Breath Actuated Nebulizer delivers a high respirable dose and an optimal particle size to reach the therapeutically important areas of the lungs. Proprietary one-way valve provides protection for clinicians and family members against dangerous second hand aerosols, which may carry harmful viruses. Breath actuated technology maintains available drug during exhalation phase and breaks in treatment to guard against costly repeat therapie